ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "meta-analysis"

  • Abstract Number: 1806 • ACR Convergence 2023

    The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis

    Daming Shao1, Jiyoung Seo1, Shaunak Mangeshkar1, Natalia Nazarenko1, Stepan Esagian1, Leonidas Palaiodimos1 and Damianos Kokkinidis2, 1Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, 2Yale University School of Medicine, New Haven, CT

    Background/Purpose: Cardiac sarcoidosis (CS) results from granulomatous infiltrating of the myocardium and manifests as an extended clinical spectrum from silence to conduction disturbances, ventricular tachyarrhythmias,…
  • Abstract Number: 0425 • ACR Convergence 2023

    Long-term Safety of Rituximab in Rheumatoid Arthritis: A Systematic Review and Meta-analysis

    Ioasaf Karafotias, Joshua Rothwell, Maryam Adas, Bechman Katie, Mark Russell, Sam Norton and James Galloway, King's College London, London, United Kingdom

    Background/Purpose: Rituximab targets CD20-bearing B cells and is used to treat Rheumatoid Arthritis (RA). Common Variable Immune Deficiency (CVID) is a primary immune deficiency syndrome…
  • Abstract Number: 1861 • ACR Convergence 2023

    Efficacy of Non-pharmacological Interventions: A Systematic Review Informing the 2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases

    Eduardo Santos1, Bayram Farisogullari2, Emma Dures3, Rinie Geenen4 and Pedro Machado5, 1Health Sciences Research Unit: Nursing (UICISA: E), Nursing School of Coimbra (ESEnfC), Coimbra, Portugal, 2Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 3Academic Rheumatology, Bristol Royal Infirmary; and Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 4Utrecht University, Vorstenbosch, Netherlands, 5Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK., London, United Kingdom

    Background/Purpose: To identify the best evidence on the efficacy of non-pharmacological interventions in reducing fatigue in people with I-RMDs and to summarise their safety in…
  • Abstract Number: 0758 • ACR Convergence 2023

    Clinical and Biological Characteristics of Children and Adults Affected with Still’s Disease: A Systematic Review and Meta-analysis Informing the 2023 EULAR/PReS Recommendations for the Diagnosis and Management of Systemic Juvenile Idiopathic Arthritis and Adult-onset Still’s Disease

    STEPHANE MITROVIC1, Arianna De Matteis2, Sara Bindoli3, Fabrizio De Benedetti4, Bruno Fautrel5, Loreto Carmona6 and On Behalf Of The Eular/PreS QoC011 Task Force Member7, 1Pitie Salpetriere Hospital, Sorbonne University, APHP, Paris, France, 2IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Italy, 3Rheumatology Unit, Dept of Medicine, University of Padova, Padova, Italy, 4Bambino Gesu Children's Hospital, Division of Rheumatology, Rome, Italy, 5Sorbonne Université APHP, Paris, France, 6Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, 7EULAR/PReS QoC011 Task Force members are: Jordi Anton, Alexandre Belot, Claudia Bracaglia, Tamas Constantin, Lorenzo Dagna, Alessandro De Bartolo, Eugen Feist, Dirk Foell, Marco Gattorno, Sophie Georgin-Lavialle, Roberto Giacomelli, Alexei Grom, Yvan Jamilloux, Katarina Laskari, Calin Lazar, Francesca Minoia, Peter Nigrovic, Filipa Oliveira Ramos, Seza Ozen, Pierre Quartier-dit-Maire, Piero Ruscitti, Erdal Sag, Sinisa Savic, Marie-Elise Truchetet, Bas Vastert, Tanita Wilhelmer, Carine Wouters., Paris, France

    Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD) are part of the non-familial (sporadic) systemic inflammatory disorders and are frequently mentioned as…
  • Abstract Number: 1956 • ACR Convergence 2023

    Rituximab Treatment in Adult Patients with Idiopathic Inflammatory Myositis (IIM): A Systematic Review and Meta-analysis

    Lilian Otalora Rojas1, Karishma Ramsubeik2, Luis Sanchez-Ramos2, Shastri Motilal3, Jasvinder Singh4 and Gurjit S Kaeley5, 1University of Florida, Ponte Vedra Beach, FL, 2University of Florida, Jacksonville, FL, 3The University of the West Indies, St. Augustine, Trinidad and Tobago, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Autoimmune myositis involves a spectrum of rare autoimmune disorders characterized by inflammation and damage to skeletal muscles. The management of these challenging conditions often…
  • Abstract Number: 0971 • ACR Convergence 2023

    Network Meta Analyses of the Effectiveness and Safety Profiles of Janus Kinase Inhibitors and Biologic Agents in Treating Children with Non-systemic Juvenile Idiopathic Arthritis (nsJIA)

    Bin Huang1, Yuxiang Li2, Xiaomeng Yue3, Sandra Andorf2, Daniel J Lovell4 and Hermine Brunner5, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3James L. Winkle College Pharmacy, Cincinnati, OH, 4UC Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, OH, 5Cincinnati Children's Hospital Medical Center, Division of Rheumatology, Cincinnati, OH

    Background/Purpose: Tofacitinib (TOFA, NCT02592434) and Baricitinib (BARI, NCT03773978) are Janus kinase inhibitors (JAKi) that are approved for or being tested for nsJIA treatment. We aim…
  • Abstract Number: 2052 • ACR Convergence 2023

    Risk Factors for Hospitalization for SARS-CoV-2 in Pediatric Patients with Rheumatic Diseases: A Systematic Review and Meta-analysis

    Qianzi Zhao1, Beth Wallace2, Lawrence Jung3 and Tova Ronis4, 1Trinity Health Ann Arbor, Ann Arbor, MI, 2Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3Jung Medical, Cedar Falls, IA, 4Children's National Hospital, Chevy Chase, MD

    Background/Purpose: Among adults who develop SARS-CoV-2 infection, those with rheumatic diseases (RDs) have similar hospitalization rates compared to those without RDs. Similar comparisons are lacking…
  • Abstract Number: 1111 • ACR Convergence 2023

    Urate-Lowering Therapy Is Associated with a Reduced Risk of Arrhythmias: A Systematic Review and Meta-analysis

    Palapun Waitayangkoon1, Tatchaya Kanthajan2 and Thiratest Leesutipornchai3, 1MetroWest Medical Center, Framingham, MA, 2Srinakharinwirot University, Bangkok, Thailand, 3University of Hawaii, Honolulu, HI

    Background/Purpose: Recent studies have suggested that hyperuricemia is significantly associated with an increased prevalence of atrial and ventricular arrhythmias and urate-lowering therapy (ULT) may provide…
  • Abstract Number: 2340 • ACR Convergence 2023

    Multi-targeted Therapy Better in Achieving Complete Response in Lupus Nephritis: A Systematic Review and Meta-analysis

    Omer Pamuk1, Bisma Shaikh2, Saif Khan3, Ali Abbas4, Sarah Abi Doumeth5 and sarfaraz Hasni6, 1University Hospitals Cleveland Medical Center, Cleveland, OH, 2Jinnah Sindh Medical University, Karachi, Pakistan, 3College of Medical and Dental Sciences, Birmingham, United Kingdom, 4Alabama College of Osteopathic Medicine, Dothan, AL, 5Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, 6Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: The overall management of SLE and Lupus Nephritis (LN) has significantly improved over the last four decades.Recently great therapeutic strides have been made in…
  • Abstract Number: 1187 • ACR Convergence 2023

    Post-hoc Analysis of Individual Questions from the Australian/Canadian Osteoarthritis Hand Index from a Randomized, Double-blind, Placebo-controlled Trial of Patients with Hand OA

    Karin Nicholson1, Edwin Sanchez1, Wendy Wright2, Joel Block3 and Richard Petruschke1, 1Haleon, Warren, NJ, 2Wright & Associates Family Healthcare, Amherst, NH, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Hand osteoarthritis (OA) is a frequently occurring form of OA characterized by symptoms including joint pain, stiffness, and swelling which affect performance of activities…
  • Abstract Number: 2550 • ACR Convergence 2023

    The Incidence of Uveitis in Patients with Axial Spondylarthritis Treated with Biologics or Targeted Synthetics: A Systematic Review and Network Meta-analysis

    Zijing Yang1, Maryam Adas1, Bechman Katie1, Deepak Nagra1, Ali Soykan Uguzlar1, Mark Russell1, Nicky Wilson2, Sophia Steer1, Sam Norton1 and James Galloway1, 1King's College London, London, United Kingdom, 2King's College Hospital, London, United Kingdom

    Background/Purpose: Anterior uveitis (AU) is one of the commonly observed extraspinal manifestations in Axial spondyloarthritis (AxSpA). Data on the protective effects of targeted immunomodulatory therapies…
  • Abstract Number: 1215 • ACR Convergence 2023

    Efficacy of Pharmacological Interventions: A Systematic Review Informing the 2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases

    Bayram Farisogullari1, Eduardo Santos2, Emma Dures3, Rinie Geenen4 and Pedro Machado5, 1Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 2Health Sciences Research Unit: Nursing (UICISA: E), Nursing School of Coimbra (ESEnfC), Coimbra, Portugal, 3Academic Rheumatology, Bristol Royal Infirmary; and Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 4Utrecht University, Vorstenbosch, Netherlands, 5Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK., London, United Kingdom

    Background/Purpose: To identify the best evidence on the efficacy of pharmacological interventions in reducing fatigue in people with I-RMDs and to summarise their safety in…
  • Abstract Number: 1260 • ACR Convergence 2023

    Optimal Approaches for Reducing Depressive Symptoms in Rheumatoid Arthritis Patients Based on Psychological Interventions: A Systematic Review and Network Meta-analysis

    Zhang Lijuan and Wu Beiwen, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Background/Purpose: In recent years, numerous psychological interventions for rheumatoid arthritis (RA) patients have been developed. However, it remains unclear which psychological interventions are effective and…
  • Abstract Number: 1400 • ACR Convergence 2023

    Achieving ASDAS Inactive Disease Status in Axial Spondyloarthritis: A Systematic Review and Meta-analysis

    Sarah Abi Doumeth1, Omer Pamuk2 and Marina Nighat Magrey3, 1Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, 2Division of Rheumatology, Case Western Reserve University/University Hospitals, Cleveland, OH, 3Case Western Reserve University, University Hospitals, Cleveland, OH

    Background/Purpose: ASDAS-CRP is a composite score that measures disease activity in axial spondyloarthritis (axSpA) and is based on patient-reported outcomes and objective measures of inflammation.…
  • Abstract Number: 1464 • ACR Convergence 2023

    Lupus Flares More Common in Patients on Dialysis Compared to After Renal Transplant: A Systematic Review and Meta-analysis

    Omer Pamuk1, Ansaam Daoud2, Loai Dweik3, Niraj Desai4 and sarfaraz Hasni5, 1University Hospitals Cleveland Medical Center, Cleveland, OH, 2University Hospitals, Case Western Reserve University, Akron, OH, 3Cleveland Clinic Akron General, Akron, OH, 4Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, OH, 5Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: End-stage renal disease (ESRD) may develop in up to 20% of patients with lupus nephritis (LN). The SLE disease activity generally declines after the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology